Luca Schneller-Pavelescu Apetrei

9PUBLICATIONS
28CO-AUTHORS
Rheumatology and arthritisHaematological tumoursPredictive and prognostic markersGene and molecular therapyDemography not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 06, 2026
Association Between Inflammatory Cytokines and Systemic Inflammation Indices in Patients With Psoriasis: A Cross-Sectional Study.

Luca Schneller-Pavelescu, Maria-José Sánchez-Pujol, Esther Caparros-Cayuela

|Dec 05, 2025
Efficacy and Safety of Risankizumab in Psoriatic Patients With a History of Malignancy: Real-World Evidence From a Multicentre Spanish Study.

Javier Mataix Díaz, Sergio Santos Alarcón, Isabel Belinchón Romero

|Sep 11, 2025
Tildrakizumab in Psoriatic Patients With Current or Past Malignancy: A Real-Life Cohort and Literature Review.

Ofelia Baniandrés, Inmaculada Balaguer Franch, Eva Vilarrasa Rull

|Mar 25, 2022
Switch from ustekinumab to guselkumab in patients with psoriasis in real clinical practice using the "minimal disease activity" parameter.

Jorge Magdaleno-Tapial, Sergio Santos-Alarcón, Marta Carolina Serra-Torres

|Sep 09, 2019
Image Gallery: Segmental neurofibromatosis type 1 on the face. A 30-year delay in diagnosis.

E Vergara-de Caso, L Schneller-Pavelescu, M C Martínez-Hergueta

|Feb 28, 2019
Presentation of pseudohypoparathyroidism and pseudopseudohypoparathyroidism with skin lesions: Case reports and review.

Luca Schneller-Pavelescu, Eduardo Vergara de Caso, Natalia Pastor-Tomás

Pageof 2

Frequent Collaborators

3 joint publications

Gemma Ochando-Ibernón

2 joint publications

Ofelia Baniandrés Rodríguez

2 joint publications

Adrián Ballano Ruiz

2 joint publications

Jorge Magdaleno-Tapial